Top compounds associated with response to TGFB2


Feature Type Standardized
Nominal ANOVA
mRNA Bosutinib FIMM pan-cancer AAC -0.65 0.6
mRNA Erlotinib UHNBreast pan-cancer AAC -0.42 0.1
mRNA temsirolimus FIMM pan-cancer AAC -0.27 0.1
mRNA GDC-0449 FIMM pan-cancer AAC -0.25 0.2
mRNA Panobinostat CCLE pan-cancer AAC -0.25 1e-07
mRNA 17-AAG FIMM pan-cancer AAC -0.22 0.2
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.22 0.006
mRNA Bicalutamide FIMM pan-cancer AAC -0.21 0.2
mRNA Erlotinib FIMM pan-cancer AAC -0.18 0.3
mRNA Irinotecan CCLE pan-cancer AAC -0.17 0.008
Download CSV